Publikationen von Sandip Murarka
Alle Typen
Zeitschriftenartikel (11)
1.
Zeitschriftenartikel
PDEδ inhibition impedes the proliferation and survival of human colorectal cancer cell lines harboring oncogenic KRas. International Journal of Cancer, S. 1 - 36 (2018)
2.
Zeitschriftenartikel
24 (5), S. 589 - 597 (2017)
Covalent Protein Labeling at Glutamic Acids. Cell chemical biology 3.
Zeitschriftenartikel
56 (9), S. 2423 - 2428 (2017)
A PDE6δ-KRas Inhibitor Chemotype with up to Seven H-Bonds and Picomolar Affinity that Prevents Efficient Inhibitor Release by Arl2. Angewandte Chemie International Edition 4.
Zeitschriftenartikel
129 (9), S. 2463 - 2468 (2017)
A PDE6d-KRas Inhibitor Chemotype with up to Seven H-Bonds and Picomolar Affinity that Prevents Efficient Inhibitor Release by Arl2. Angewandte Chemie 5.
Zeitschriftenartikel
49 (1), S. 87 - 95 (2017)
Biology-Oriented Synthesis of 3,3-Spiro(2-tetrahydrofuranyl)oxindoles. Synthesis 6.
Zeitschriftenartikel
7, 11360, S. 1 - 9 (2016)
Identification of pyrazolopyridazinones as PDEδ inhibitors. Nature Communications 7.
Zeitschriftenartikel
23 (25), S. 6083 - 6093 (2016)
Development of Pyridazinone Chemotypes Targeting the PDEδ Prenyl Binding Site. Chemistry – A European Journal 8.
Zeitschriftenartikel
Oxidative Heterocycle Formation Using Hypervalent Iodine(III) Reagents. Topics in Current Chemistry, S. 1 - 30 (2015)
9.
Zeitschriftenartikel
54 (26), S. 7653 - 7656 (2015)
Rhodium(II)-Catalyzed Enantioselective Synthesis of Troponoids. Angewandte Chemie International Edition 10.
Zeitschriftenartikel
127, S. 1 - 5 (2015)
Rhodium(II)-Catalyzed Enantioselective Synthesis of Troponoids. Angewandte Chemie 11.
Zeitschriftenartikel
57 (12), S. 5435 - 5448 (2014)
Structure Guided Design and Kinetic Analysis of Highly Potent Benzimidazole Inhibitors Targeting the PDEδ Prenyl Binding Site. Journal of Medicinal Chemistry